These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7764806)

  • 1. Accelerated stability testing of bioproducts: attractions and pitfalls.
    Franks F
    Trends Biotechnol; 1994 Apr; 12(4):114-7. PubMed ID: 7764806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One- and two-stage Arrhenius models for pharmaceutical shelf life prediction.
    Fan Z; Zhang L
    J Biopharm Stat; 2015; 25(2):307-16. PubMed ID: 25358076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the shelf-life of drugs with mixed effects models.
    Chen JJ; Hwang JS; Tsong Y
    J Biopharm Stat; 1995 Mar; 5(1):131-40. PubMed ID: 7613558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Shelf-life estimation of pharmaceutical products by matrixing].
    Yoshioka S; Aso Y; Kojima S
    Eisei Shikenjo Hokoku; 1996; (114):143-4. PubMed ID: 9037887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of glass transition temperature in accelerated stability testing of amorphous solids: case study using a lyophilized aspirin formulation.
    Duddu SP; Weller K
    J Pharm Sci; 1996 Mar; 85(3):345-7. PubMed ID: 8699342
    [No Abstract]   [Full Text] [Related]  

  • 6. Stability testing requirements for vaccines--draft guidelines of the International Conference on Harmonization.
    Haase M
    Dev Biol Stand; 1996; 87():309-18. PubMed ID: 8854031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of in-use photostability: proposed guidance for photostability testing and labeling to support the administration of photosensitive pharmaceutical products, part 1: drug products administered by injection.
    Baertschi SW; Clapham D; Foti C; Jansen PJ; Kristensen S; Reed RA; Templeton AC; Tønnesen HH
    J Pharm Sci; 2013 Nov; 102(11):3888-99. PubMed ID: 24009146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-phase shelf-life estimation.
    Shao J; Chow SC
    Stat Med; 2001 Apr; 20(8):1239-48. PubMed ID: 11304739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the dissolution rate of poorly soluble drugs by solid crystal suspensions.
    Thommes M; Ely DR; Carvajal MT; Pinal R
    Mol Pharm; 2011 Jun; 8(3):727-35. PubMed ID: 21344937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated aging: prediction of chemical stability of pharmaceuticals.
    Waterman KC; Adami RC
    Int J Pharm; 2005 Apr; 293(1-2):101-25. PubMed ID: 15778049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the research of amorphous pharmaceuticals].
    Ying J; Lü Y; Du GH
    Yao Xue Xue Bao; 2009 May; 44(5):443-8. PubMed ID: 19618716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quality control and stability testing of homeopathic preparations.
    Marotta M; Addabbo I; Kosasi S
    Boll Chim Farm; 1998 Nov; 137(10):439-41. PubMed ID: 9880948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality control of anti-tuberculosis FDC formulations in the global market: part II-accelerated stability studies.
    Ashokraj Y; Kohli G; Kaul CL; Panchagnula R
    Int J Tuberc Lung Dis; 2005 Nov; 9(11):1266-72. PubMed ID: 16333936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The physical and chemical stability of anti-tuberculosis fixed-dose combination products under accelerated climatic conditions.
    Bhutani H; Mariappan TT; Singh S
    Int J Tuberc Lung Dis; 2004 Sep; 8(9):1073-80. PubMed ID: 15455591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjusting dissolution specifications for the variability induced by storage conditions.
    Reynolds JM; Rogers DH
    J Biopharm Stat; 2000 Aug; 10(3):425-31. PubMed ID: 10959921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
    Bouligand J; Storme T; Laville I; Mercier L; Oberlin O; Vassal G; Bourget P; Paci A
    J Pharm Biomed Anal; 2005 Jun; 38(1):180-5. PubMed ID: 15907638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A matrixed approach to long-term stability testing of pharmaceutical products.
    Golden MH; Cooper DC; Riebe MT; Carswell KE
    J Pharm Sci; 1996 Feb; 85(2):240-5. PubMed ID: 8683455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical evaluation for stability studies under stress storage conditions.
    Gil-Alegre ME; Bernabeu JA; Camacho MA; Torres-Suarez AI
    Farmaco; 2001 Nov; 56(11):877-83. PubMed ID: 11765040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting the stability of biological standards and products.
    Kirkwood TB
    Biometrics; 1977 Dec; 33(4):736-42. PubMed ID: 588659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory requirements for veterinary vaccine stability in the European Community.
    Fawthrop D
    Dev Biol Stand; 1996; 87():319-27. PubMed ID: 8854032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.